البحث عن طبيب

John J. Dillon, M.D.

  1. Internist
  2. Nephrologist
طلب موعد

المنشورات

  1. Harmon DM, Heinrich CK, Dillon JJ, Carter RE, Kashani KB, Attia ZI, Friedman PA, Jentzer JC. Mortality Risk Stratification Utilizing Artificial Intelligence Electrocardiogram for Hyperkalemia in Cardiac Intensive Care Unit Patients. JACC Adv. 2024 Sep; 3 (9):101169 Epub 2024 Aug 21
    View PubMed
  2. Harmon DM, Liu K, Dugan J, Jentzer JC, Attia ZI, Friedman PA, Dillon JJ. Validation of Noninvasive Detection of Hyperkalemia by Artificial Intelligence-Enhanced Electrocardiography in High Acuity Settings. Clin J Am Soc Nephrol 2024 Aug 1; 19 (8):952-958 Epub 2024 June 21
    View PubMed
  3. Zoghby ZM, Kattah AG, Havlovic K, Stacy D, d’Uscio M, Balderes KP, Seelman J, Johnson KF, Dillon JJ, Bishop A, Vaughn J, Williams AW, Chaudhry R. Transforming Home Dialysis Management of Patients with Advanced Kidney Disease Using an Intelligent Automated Application in Practice Mayo Clinic Proceedings: Digital Health. 2023; 1(3):258-266. Epub 2023 May 09.
  4. Miao J, Olson E, Houlihan S, Kattah A, Dillon J, Zoghby Z. Effects of SARS-CoV-2 vaccination on the severity of COVID-19 infection in patients on chronic dialysis. J Nephrol. 2023 Jun; 36 (5):1321-1328 Epub 2023 Apr 05
    View PubMed
  5. Thongprayoon C, Pattharanitima P, Kattah AG, Mao MA, Keddis MT, Dillon JJ, Kaewput W, Tangpanithandee S, Krisanapan P, Qureshi F, Cheungpasitporn W. Explainable Preoperative Automated Machine Learning Prediction Model for Cardiac Surgery-Associated Acute Kidney Injury. J Clin Med. 2022 Oct 24; 11 (21)
    View PubMed
  6. Thongprayoon C, Kattah AG, Mao MA, Keddis MT, Pattharanitima P, Vallabhajosyula S, Nissaisorakarn V, Erickson SB, Dillon JJ, Garovic VD, Cheungpasitporn W. Distinct phenotypes of hospitalized patients with hyperkalemia by machine learning consensus clustering and associated mortality risks. QJM. 2022 Jul 9; 115 (7):442-449
    View PubMed
  7. Thongprayoon C, Mao MA, Keddis MT, Kattah AG, Chong GY, Pattharanitima P, Nissaisorakarn V, Garg AK, Erickson SB, Dillon JJ, Garovic VD, Cheungpasitporn W. Hypernatremia subgroups among hospitalized patients by machine learning consensus clustering with different patient survival. J Nephrol. 2022 Apr; 35 (3):921-929 Epub 2021 Oct 08
    View PubMed
  8. Thongprayoon C, Mao MA, Kattah AG, Keddis MT, Pattharanitima P, Erickson SB, Dillon JJ, Garovic VD, Cheungpasitporn W. Subtyping hospitalized patients with hypokalemia by machine learning consensus clustering and associated mortality risks. Clin Kidney J. 2022 Feb; 15 (2):253-261 Epub 2021 Oct 12
    View PubMed
  9. Thongprayoon C, Sy-Go JPT, Nissaisorakarn V, Dumancas CY, Keddis MT, Kattah AG, Pattharanitima P, Vallabhajosyula S, Mao MA, Qureshi F, Garovic VD, Dillon JJ, Erickson SB, Cheungpasitporn W. Machine Learning Consensus Clustering Approach for Hospitalized Patients with Dysmagnesemia. Diagnostics (Basel). 2021 Nov 15; 11 (11)
    View PubMed
  10. Pattharanitima P, Thongprayoon C, Petnak T, Srivali N, Gembillo G, Kaewput W, Chesdachai S, Vallabhajosyula S, O'Corragain OA, Mao MA, Garovic VD, Qureshi F, Dillon JJ, Cheungpasitporn W. Machine Learning Consensus Clustering Approach for Patients with Lactic Acidosis in Intensive Care Units. J Pers Med. 2021 Nov 2; 11 (11) Epub 2021 Nov 02
    View PubMed
  11. Pattharanitima P, Thongprayoon C, Kaewput W, Qureshi F, Qureshi F, Petnak T, Srivali N, Gembillo G, O'Corragain OA, Chesdachai S, Vallabhajosyula S, Guru PK, Mao MA, Garovic VD, Dillon JJ, Cheungpasitporn W. Machine Learning Prediction Models for Mortality in Intensive Care Unit Patients with Lactic Acidosis. J Clin Med. 2021 Oct 28; 10 (21)
    View PubMed
  12. Thongprayoon C, Dumancas CY, Nissaisorakarn V, Keddis MT, Kattah AG, Pattharanitima P, Petnak T, Vallabhajosyula S, Garovic VD, Mao MA, Dillon JJ, Erickson SB, Cheungpasitporn W. Machine Learning Consensus Clustering Approach for Hospitalized Patients with Phosphate Derangements. J Clin Med. 2021 Sep 27; 10 (19) Epub 2021 Sept 27
    View PubMed
  13. Thongprayoon C, Vaitla P, Nissaisorakarn V, Mao MA, Genovez JLZ, Kattah AG, Pattharanitima P, Vallabhajosyula S, Keddis MT, Qureshi F, Dillon JJ, Garovic VD, Kashani KB, Cheungpasitporn W. Clinically Distinct Subtypes of Acute Kidney Injury on Hospital Admission Identified by Machine Learning Consensus Clustering. Med Sci (Basel). 2021 Sep 24; 9 (4) Epub 2021 Sept 24
    View PubMed
  14. Thongprayoon C, Nissaisorakarn V, Pattharanitima P, Mao MA, Kattah AG, Keddis MT, Dumancas CY, Vallabhajosyula S, Petnak T, Erickson SB, Dillon JJ, Garovic VD, Kashani KB, Cheungpasitporn W. Subtyping Hyperchloremia among Hospitalized Patients by Machine Learning Consensus Clustering. Medicina (Kaunas). 2021 Aug 30; 57 (9)
    View PubMed
  15. Thongprayoon C, Hansrivijit P, Mao MA, Vaitla PK, Kattah AG, Pattharanitima P, Vallabhajosyula S, Nissaisorakarn V, Petnak T, Keddis MT, Erickson SB, Dillon JJ, Garovic VD, Cheungpasitporn W. Machine Learning Consensus Clustering of Hospitalized Patients with Admission Hyponatremia. Diseases. 2021 Aug 1; 9 (3) Epub 2021 Aug 01
    View PubMed
  16. Shawwa K, Kompotiatis P, Jentzer JC, Wiley BM, Williams AW, Dillon JJ, Albright RC, Kashani KB. Hypotension within one-hour from starting CRRT is associated with in-hospital mortality. J Crit Care. 2019 Dec; 54:7-13 Epub 2019 July 08
    View PubMed
  17. Abudan AA, Isath A, Ryan JD, Henrich MJ, Dugan JL, Attia ZI, Ladewig DJ, Dillon JJ, Friedman PA. Safety and compatibility of smart device heart rhythm monitoring in patients with cardiovascular implantable electronic devices. J Cardiovasc Electrophysiol. 2019 Sep; 30 (9):1602-1609 Epub 2019 June 25
    View PubMed
  18. Galloway CD, Valys AV, Shreibati JB, Treiman DL, Petterson FL, Gundotra VP, Albert DE, Attia ZI, Carter RE, Asirvatham SJ, Ackerman MJ, Noseworthy PA, Dillon JJ, Friedman PA. Development and Validation of a Deep-Learning Model to Screen for Hyperkalemia From the Electrocardiogram. JAMA Cardiol. 2019 May 1; 4 (5):428-436
    View PubMed
  19. Attia Z, Friedman PA, Ladewig DJ, Satam GC, Dugan JL, Sepir Y, Sadot D, Geva A, Somers VR, Asirvatham SJ, Ackerman MJ, Bennet KE, Singh B, Dillon JJ. ECG-based Potassium Measurement is Unaffected by Errors in Blood Potassium Measurement During Hemodialysis Journal of Clinical & Experimental Nephrology. 2018; 3(2):13-16.
  20. Chen JC, Thorsteinsdottir B, Vaughan LE, Feely MA, Albright RC, Onuigbo M, Norby SM, Gossett CL, D'Uscio MM, Williams AW, Dillon JJ, Hickson LJ. End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy. Clin J Am Soc Nephrol. 2018 Aug 7; 13 (8):1172-1179 Epub 2018 July 19
    View PubMed
  21. Friedman PA, Scott CG, Bailey K, Baumann NA, Albert D, Attia ZI, Ladewig DJ, Yasin O, Dillon JJ, Singh B. Errors of Classification With Potassium Blood Testing: The Variability and Repeatability of Critical Clinical Tests. Mayo Clin Proc. 2018 May; 93 (5):566-572
    View PubMed
  22. Dillon JJ, Friedman PA. Using AI to Invent New Medical Tests (Invited Article) Harvard Business Review. 2018.
  23. Haffar S, Bazerbachi F, Leise MD, Dillon JJ, Albright RC, Murad MH, Kamath PS, Watt KD. Systematic review with meta-analysis: the association between hepatitis E seroprevalence and haemodialysis. Aliment Pharmacol Ther. 2017 Nov; 46 (9):790-799 Epub 2017 Sept 04
    View PubMed
  24. Yasin OZ, Attia Z, Dillon JJ, DeSimone CV, Sapir Y, Dugan J, Somers VK, Ackerman MJ, Asirvatham SJ, Scott CG, Bennet KE, Ladewig DJ, Sadot D, Geva AB, Friedman PA. Noninvasive blood potassium measurement using signal-processed, single-lead ecg acquired from a handheld smartphone. J Electrocardiol. 2017 Sep-Oct; 50 (5):620-625 Epub 2017 June 08
    View PubMed
  25. Safadi S, Albright RC Jr, Dillon JJ, Williams AW, Alahdab F, Brown JK, Severson AL, Kremers WK, Ryan MA, Hogan MC. Prospective Study of Routine Heparin Avoidance Hemodialysis in a Tertiary Acute Care Inpatient Practice. Kidney Int Rep. 2017 Jul; 2(4):695-704. Epub 2017 Mar 16.
    View PubMed
  26. Hasin T, Grupper A, Dillon JJ, Maleszewski JJ, Li Z, Topilsky Y, Frantz RP, Edwards BS, Pereira NL, Maltais S, Stulak JM, Joyce L, Daly R, Park SJ, Kushwaha SS. Early Gains in Renal Function Following Implantation of HeartMate II Left Ventricular Assist Devices May Not Persist to One Year. ASAIO J. 2017 Jul/Aug; 63 (4):401-407
    View PubMed
  27. Cheungpasitporn W, Hui J, Kashani KB, Wittwer ED, Albright RC Jr, Dillon JJ. High-dose hydroxocobalamin for vasoplegic syndrome causing false blood leak alarm. Clin Kidney J. 2017 Jun; 10 (3):357-362 Epub 2017 Mar 15
    View PubMed
  28. New AM, Nystrom EM, Frazee E, Dillon JJ, Kashani KB, Miles JM. Continuous renal replacement therapy: a potential source of calories in the critically ill. Am J Clin Nutr. 2017 Jun; 105 (6):1559-1563 Epub 2017 May 03
    View PubMed
  29. El-Azhary RA, Patzelt MT, McBane RD, Weaver AL, Albright RC, Bridges AD, Claus PL, Davis MD, Dillon JJ, El-Zoghby ZM, Hickson LJ, Kumar R, McCarthy-Fruin KA, McEvoy MT, Pittelkow MR, Wetter DA, Williams AW, McCarthy JT. Calciphylaxis: A Disease of Pannicular Thrombosis. Mayo Clin Proc. 2016 Oct; 91 (10):1395-1402
    View PubMed
  30. McCarthy JT, El-Azhary RA, Patzelt MT, Weaver AL, Albright RC, Bridges AD, Claus PL, Davis MD, Dillon JJ, El-Zoghby ZM, Hickson LJ, Kumar R, McBane RD, McCarthy-Fruin KA, McEvoy MT, Pittelkow MR, Wetter DA, Williams AW. Survival, Risk Factors, and Effect of Treatment in 101 Patients With Calciphylaxis. Mayo Clin Proc. 2016 Oct; 91 (10):1384-1394
    View PubMed
  31. Hickson LJ, Negrotto SM, Onuigbo M, Scott CG, Rule AD, Norby SM, Albright RC, Casey ET, Dillon JJ, Pellikka PA, Pislaru SV, Best PJM, Villarraga HR, Lin G, Williams AW, Nkomo VT. Echocardiography Criteria for Structural Heart Disease in Patients With End-Stage Renal Disease Initiating Hemodialysis. J Am Coll Cardiol. 2016 Mar 15; 67 (10):1173-1182
    View PubMed
  32. Attia ZI, DeSimone CV, Dillon JJ, Sapir Y, Somers VK, Dugan JL, Bruce CJ, Ackerman MJ, Asirvatham SJ, Striemer BL, Bukartyk J, Scott CG, Bennet KE, Ladewig DJ, Gilles EJ, Sadot D, Geva AB, Friedman PA. Novel Bloodless Potassium Determination Using a Signal-Processed Single-Lead ECG. J Am Heart Assoc. 2016 Jan 25; 5 (1)
    View PubMed
  33. Hamadah AM, Beaulieu LM, Wilson JW, Aksamit TR, Gregoire JR, Williams AW, Dillon JJ, Albright RC, Onuigbo M, Iyer VK, Hickson LJ. Tolerability and Healthcare Utilization in Maintenance Hemodialysis Patients Undergoing Treatment for Tuberculosis-Related Conditions. Nephron. 2016; 132 (3):198-206 Epub 2016 Feb 10
    View PubMed
  34. Albright RC Jr, Dillon JJ, Hocum CL, Stubbs JR, Johnson PM, Hickson LJ, Williams AW, Dingli D, McCarthy JT. Total Red Blood Cell Transfusions for Chronic Hemodialysis Patients in a Single Center, 2009-2013. Nephron. 2016; 133 (1):23-34 Epub 2016 Apr 16
    View PubMed
  35. Cheungpasitporn W, Zand L, Dillon JJ, Qian Q, Leung N. Lactate clearance and metabolic aspects of continuous high-volume hemofiltration. Clin Kidney J. 2015 Aug; 8 (4):374-7 Epub 2015 June 17
    View PubMed
  36. Thongprayoon C, Cheungpasitporn W, Shah IK, Kashyap R, Park SJ, Kashani K, Dillon JJ. Long-term Outcomes and Prognostic Factors for Patients Requiring Renal Replacement Therapy After Cardiac Surgery. Mayo Clin Proc. 2015 Jul; 90 (7):857-64
    View PubMed
  37. Hickson LJ, Chaudhary S, Williams AW, Dillon JJ, Norby SM, Gregoire JR, Albright RC Jr, McCarthy JT, Thorsteinsdottir B, Rule AD. Predictors of outpatient kidney function recovery among patients who initiate hemodialysis in the hospital. Am J Kidney Dis. 2015 Apr; 65 (4):592-602 Epub 2014 Nov 05
    View PubMed
  38. Akhoundi A, Singh B, Vela M, Chaudhary S, Monaghan M, Wilson GA, Dillon JJ, Cartin-Ceba R, Lieske JC, Gajic O, Kashani K. Incidence of Adverse Events during Continuous Renal Replacement Therapy. Blood Purif. 2015; 39 (4):333-9 Epub 2015 May 22
    View PubMed
  39. Fervenza FC, Canetta PA, Barbour SJ, Lafayette RA, Rovin BH, Aslam N, Hladunewich MA, Irazabal MV, Sethi S, Gipson DS, Reich HN, Brenchley P, Kretzler M, Radhakrishnan J, Hebert LA, Gipson PE, Thomas LF, McCarthy ET, Appel GB, Jefferson JA, Eirin A, Lieske JC, Hogan MC, Greene EL, Dillon JJ, Leung N, Sedor JR, Rizk DV, Blumenthal SS, Lasic LB, Juncos LA, Green DF, Simon J, Sussman AN, Philibert D, Cattran DC, Mentor Consortium group. A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR). Nephron. 2015; 130 (3):159-68 Epub 2015 June 12
    View PubMed
  40. Dillon JJ, DeSimone CV, Sapir Y, Somers VK, Dugan JL, Bruce CJ, Ackerman MJ, Asirvatham SJ, Striemer BL, Bukartyk J, Scott CG, Bennet KE, Mikell SB, Ladewig DJ, Gilles EJ, Geva A, Sadot D, Friedman PA. Noninvasive potassium determination using a mathematically processed ECG: proof of concept for a novel "blood-less, blood test". J Electrocardiol. 2015 Jan-Feb; 48 (1):12-8 Epub 2014 Oct 18
    View PubMed
  41. Lim JY, Deo SV, Jung SH, Altarabsheh SE, Erwin PJ, Dillon JJ, Park SJ. Does off-pump coronary artery bypass confer any advantage in patients with end-stage renal failure? A systematic review and meta-analysis. Heart Lung Circ. 2015 Jan; 24(1):55-61. Epub 2014 Jun 27.
    View PubMed
  42. Patel K, Dillon JJ, Leung N, Bomback AS, Appel GB, D'Agati V, Canetta PA. Use of bortezomib in heavy-chain deposition disease: a report of 3 cases. Am J Kidney Dis. 2014 Jul; 64(1):123-7. Epub 2014 Mar 05.
    View PubMed
  43. Deo SV, Shah IK, Dunlay SM, Lim JY, Erwin PJ, Dillon JJ, Park SJ. Coronary artery bypass grafting versus drug-eluting stents in patients with end-stage renal disease. J Card Surg. 2014 Mar; 29(2):163-9.
    View PubMed
  44. Deo SV, Sharma V, Altarabsheh SE, Hasin T, Dillon J, Shah IK, Durham LA 3rd, Stulak JM, Daly RC, Joyce LD, Park SJ. Hepatic and renal function with successful long-term support on a continuous flow left ventricular assist device. Heart Lung Circ. 2014 Mar; 23(3):229-33. Epub 2013 Aug 29.
    View PubMed
  45. Safadi S, Mao M, Dillon JJ. Ceftriaxone-induced acute encephalopathy in a peritoneal dialysis patient. Case Rep Nephrol. 2014; 2014:108185 Epub 2014 Dec 07
    View PubMed
  46. McCarthy JT, Hocum CL, Albright RC, Rogers J, Gallaher EJ, Steensma DP, Gudgell SF, Bergstralh EJ, Dillon JC, Hickson LJ, Williams AW, Dingli D. Biomedical system dynamics to improve anemia control with darbepoetin alfa in long-term hemodialysis patients. Mayo Clin Proc. 2014 Jan; 89 (1):87-94
    View PubMed
  47. Schoonover KL, Hickson LJ, Norby SM, Hogan MC, Chaudhary S, Albright RC Jr, Dillon JJ, McCarthy JT, Williams AW. Risk factors for hospitalization among older, incident haemodialysis patients. Nephrology (Carlton). 2013 Nov; 18 (11):712-7
    View PubMed
  48. Deo SV, Shah IK, Dunlay SM, Erwin PJ, Dillon JM, Park SJ. Myocardial revascularisation in renal dysfunction: a systematic review and meta-analysis. Heart Lung Circ. 2013 Oct; 22 (10):827-35 Epub 2013 Mar 31
    View PubMed
  49. Tumlin JA, Chawla L, Tolwani AJ, Mehta R, Dillon J, Finkel KW, DaSilva JR, Astor BC, Yevzlin AS, Humes HD. The effect of the selective cytopheretic device on acute kidney injury outcomes in the intensive care unit: a multicenter pilot study. Semin Dial. 2013 Sep-Oct; 26(5):616-23. Epub 2012 Oct 29.
    View PubMed
  50. Irazabal MV, Eirin A, Lieske J, Beck LH, Sethi S, Borland TM, Dillon JJ, Nachman PH, Nasr SH, Cornell LD, Leung N, Cattran DC, Fervenza FC. Low- and high-molecular-weight urinary proteins as predictors of response to rituximab in patients with membranous nephropathy: a prospective study. Nephrol Dial Transplant. 2013 Jan; 28 (1):137-46 Epub 2012 Sept 17
    View PubMed
  51. Dillon JJ, Hladunewich M, Haley WE, Reich HN, Cattran DC, Fervenza FC. Rituximab therapy for Type I membranoproliferative glomerulonephritis. Clin Nephrol. 2012 Apr; 77 (4):290-5
    View PubMed
  52. Schinstock CA, Albright RC, Williams AW, Dillon JJ, Bergstralh EJ, Jenson BM, McCarthy JT, Nath KA. Outcomes of arteriovenous fistula creation after the Fistula First Initiative. Clin J Am Soc Nephrol. 2011 Aug; 6 (8):1996-2002 Epub 2011 July 07
    View PubMed
  53. Fervenza FC, Abraham RS, Erickson SB, Irazabal MV, Eirin A, Specks U, Nachman PH, Bergstralh EJ, Leung N, Cosio FG, Hogan MC, Dillon JJ, Hickson LJ, Li X, Cattran DC, Mayo Nephrology Collaborative Group. Rituximab therapy in idiopathic membranous nephropathy: a 2-year study. Clin J Am Soc Nephrol. 2010 Dec; 5 (12):2188-98 Epub 2010 Aug 12
    View PubMed
  54. Lorenz EC, Vrtiska TJ, Lieske JC, Dillon JJ, Stegall MD, Li X, Bergstralh EJ, Rule AD. Prevalence of renal artery and kidney abnormalities by computed tomography among healthy adults. Clin J Am Soc Nephrol. 2010 Mar; 5 (3):431-8 Epub 2010 Jan 14
    View PubMed
  55. Lieske JC, Regnier C, Dillon JJ. Use of sevelamer hydrochloride as an oxalate binder. J Urol. 2008 Apr; 179 (4):1407-10 Epub 2008 Mar 04
    View PubMed
  56. Boseman P, Lewin M, Dillon J, Sethi S. Marfan syndrome, MPGN, and bacterial endocarditis. Am J Kidney Dis. 2008 Apr; 51(4):697-701. Epub 2008 Mar 03.
    View PubMed
  57. Fervenza FC, Cosio FG, Erickson SB, Specks U, Herzenberg AM, Dillon JJ, Leung N, Cohen IM, Wochos DN, Bergstralh E, Hladunewich M, Cattran DC. Rituximab treatment of idiopathic membranous nephropathy. Kidney Int. 2008 Jan; 73 (1):117-25 Epub 2007 Oct 17
    View PubMed
  58. Dillon JJ. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy. Semin Nephrol. 2004 May; 24 (3):218-24
    View PubMed
  59. Hartman AR, Fleming GF, Dillon JJ. Meta-analysis of adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy in postmenopausal women with estrogen receptor-positive, node-positive breast cancer. Clin Breast Cancer. 2001 Jul; 2(2):138-43; discussion 144.
    View PubMed
  60. Dillon JJ. Nephrotoxicity from nonsteroidal anti-inflammatory drugs. MDVista Journalof Medicine Sept. 2000.
  61. Dillon JJ, IgA Nephropathy. IgA Nephropathy. . MDVista Journal of Medicine. 2000 Dec.
  62. Arnow PM, Garcia-Houchins S, Neagle MB, Bova JL, Dillon JJ, Chou T. An outbreak of bloodstream infections arising from hemodialysis equipment. J Infect Dis. 1998 Sep; 178(3):783-91.
    View PubMed
  63. Hartman AR, Williams SF, Dillon JJ. Survival, disease-free survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan/cyclophosphamide vs total body irradiation: a meta-analysis. Bone Marrow Transplant. 1998 Sep; 22(5):439-43.
    View PubMed
  64. Newell KA, Millis JM, Bruce DS, Woodle ES, Cronin DC, Loss G, Grewal H, Alonso EM, Dillon JJ, Whitington PF, Thistlethwaite JR Jr. An analysis of hepatic retransplantation in children. Transplantation. 1998 May 15; 65(9):1172-8.
    View PubMed
  65. Dillon JJ, Sedmak DD, Cosio FG. Rapid-onset diabetic nephropathy in type II diabetes mellitus. Ren Fail. 1997 Nov; 19(6):819-22.
    View PubMed
  66. Dillon JJ. Fish oil therapy for IgA nephropathy: efficacy and interstudy variability. J Am Soc Nephrol. 1997 Nov; 8(11):1739-44.
    View PubMed
  67. Hebert LA, Birmingham DJ, Mahan JD, Cosio FG, Dillon JJ, Sedmak DD, Shen XP, McAllister C. Effect of enalapril therapy on glomerular accumulation of immune complexes and mesangial matrix in experimental glomerulonephritis in the nonhuman primate. Am J Kidney Dis. 1997 Aug; 30(2):243-52.
    View PubMed
  68. Birmingham DJ, Shen XP, Hartman JA, Dillon JJ, Hebert LA. Effect of chronic human recombinant erythropoietin therapy on antibody responses to immunization in chronic hemodialysis patients. Kidney Int. 1996 Aug; 50(2):543-9.
    View PubMed
  69. Hebert LA, Dillon JJ, Middendorf DF, Lewis EJ, Peter JB. Relationship between appearance of urinary red blood cell/white blood cell casts and the onset of renal relapse in systemic lupus erythematosus. Am J Kidney Dis. 1995 Sep; 26(3):432-8.
    View PubMed
  70. Cosio FG, Dillon JJ, Falkenhain ME, Tesi RJ, Henry ML, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM. Racial differences in renal allograft survival: the role of systemic hypertension. Kidney Int. 1995 Apr; 47(4):1136-41.
    View PubMed
  71. Hebert LA, Birmingham DJ, Shen XP, Brandt JT, Sedmak DD, Dillon JJ. Effect of recombinant erythropoietin therapy on autoimmunity in systemic lupus erythematosus. Am J Kidney Dis. 1994 Jul; 24(1):25-32.
    View PubMed
  72. Hebert LA, Birmingham DJ, Dillon JJ, Cosio FG, Shen XP. Erythropoietin therapy in humans increases erythrocyte expression of complement receptor type 1 (CD35). J Am Soc Nephrol. 1994 Apr; 4(10):1786-91.
    View PubMed
  73. Hebert LA, Birmingham DJ, Mahan JD, Shen XP, McAllister C, Cosio FG, Dillon JJ. Effect of chronically increased erythrocyte complement receptors on immune complex nephritis. Kidney Int. 1994 Feb; 45(2):493-9.
    View PubMed
  74. Dillon JJ. The quantitative relationship between treated blood pressure and progression of diabetic renal disease. Am J Kidney Dis. 1993 Dec; 22(6):798-802.
    View PubMed
  75. Dillon JJ, Grossman SH, Finn WF. Effect of oxypurinol on renal reperfusion injury in the rat. Ren Fail. 1993; 15(1):37-45.
    View PubMed
  76. McCormack AJ, Snipes RG, Dillon JJ, Yang JJ, Finn WF. Primary renovascular effects of erythromycin in the rat: relationship to cyclosporine nephrotoxicity. Ren Fail. 1990; 12(4):241-8.
    View PubMed
  77. Dillon JJ, Finn WF. How can the high mortality of acute renal failure be reduced? Semin Dial. 1988; 1:133-5.